ATE279179T1 - Clopidogrelbisulfathaltige tablettenzubereitung - Google Patents
Clopidogrelbisulfathaltige tablettenzubereitungInfo
- Publication number
- ATE279179T1 ATE279179T1 AT02257582T AT02257582T ATE279179T1 AT E279179 T1 ATE279179 T1 AT E279179T1 AT 02257582 T AT02257582 T AT 02257582T AT 02257582 T AT02257582 T AT 02257582T AT E279179 T1 ATE279179 T1 AT E279179T1
- Authority
- AT
- Austria
- Prior art keywords
- clopidogrel bisulfate
- preparation containing
- tablet preparation
- containing clopidogrel
- bisulfate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2363053A CA2363053C (en) | 2001-11-09 | 2001-11-09 | Clopidogrel bisulfate tablet formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE279179T1 true ATE279179T1 (de) | 2004-10-15 |
Family
ID=4170539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02257582T ATE279179T1 (de) | 2001-11-09 | 2002-11-01 | Clopidogrelbisulfathaltige tablettenzubereitung |
Country Status (6)
Country | Link |
---|---|
US (1) | US6914141B2 (de) |
EP (1) | EP1310245B1 (de) |
AT (1) | ATE279179T1 (de) |
AU (1) | AU2002301782B8 (de) |
CA (1) | CA2363053C (de) |
DE (1) | DE60201568T2 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
GB0325603D0 (en) * | 2003-11-03 | 2003-12-10 | Sandoz Ag | Organic compounds |
WO2005070464A2 (en) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of clopidogrel bisulphate |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
KR20070009851A (ko) * | 2005-07-14 | 2007-01-19 | 씨제이 주식회사 | 클로피도그렐 황산수소염 함유 약학 조성물 |
KR20070044323A (ko) * | 2005-10-24 | 2007-04-27 | 에스케이케미칼주식회사 | 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제 |
IS2385B (is) * | 2006-02-10 | 2008-07-15 | Actavis Group Hf. | Klópidógrel bísúlfat lyfjasamsetningar |
DK1847258T4 (da) | 2006-04-13 | 2013-04-15 | Acino Pharma Ag | Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
CA2873524C (en) | 2006-05-04 | 2018-02-20 | Boehringer Ingelheim International Gmbh | A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine |
EP1900358A1 (de) | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Clopidogrel enthaltende Arzneiformulierungen |
CN100400035C (zh) * | 2006-10-18 | 2008-07-09 | 深圳信立泰药业股份有限公司 | 氯吡格雷硫酸盐的固体制剂及其制备方法 |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
EP1970054A3 (de) * | 2007-03-14 | 2009-06-03 | Ranbaxy Laboratories Limited | Clopidogrel-Tabletten |
WO2008122994A2 (en) * | 2007-04-09 | 2008-10-16 | Usv Limited | Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof |
HUE053158T2 (hu) | 2007-04-27 | 2021-06-28 | Cydex Pharmaceuticals Inc | Clopidogrelt és szulfoalkiléter ciklodextrint tartalmazó készítmények és alkalmazási eljárások |
EP2095815B1 (de) * | 2008-02-26 | 2011-10-26 | Laboratorios Lesvi, S.L. | Pharmazeutische Formulierungen mit Clopidogrel |
PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
US20090264460A1 (en) * | 2008-04-21 | 2009-10-22 | Mamta Mishra | Clopidogrel pharmaceutical formulations |
ATE482961T1 (de) | 2008-04-25 | 2010-10-15 | Sandoz Ag | Hydrogensulfat von 2-acetoxy-5-(a- cyclopropylcarbonyl-2-fluorbenzyl)-4,5,6,7- tetrahydrothienoä3,2-cüpyridin und dessen zubereitung |
BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
BRPI0923121A2 (pt) | 2008-12-23 | 2015-08-11 | Boehringer Ingelheim Int | Formas salinas de compostos orgânico |
PL3100728T3 (pl) | 2009-05-13 | 2020-05-18 | Cydex Pharmaceuticals, Inc. | Kompozycje farmaceutyczne zawierające prasugrel i pochodne cyklodekstryny oraz sposoby ich wytwarzania i zastosowania |
CN102753161A (zh) | 2009-11-27 | 2012-10-24 | 贝林格尔.英格海姆国际有限公司 | 基因型糖尿病患者利用dpp-iv抑制剂例如利拉利汀的治疗 |
CN101766573B (zh) | 2010-02-05 | 2013-02-13 | 上海安必生制药技术有限公司 | 硫酸氢氯吡格雷固体制剂的制备工艺 |
WO2011138421A1 (en) | 2010-05-05 | 2011-11-10 | Boehringer Ingelheim International Gmbh | Combination therapy |
EP3124041A1 (de) | 2010-06-24 | 2017-02-01 | Boehringer Ingelheim International GmbH | Diabetestherapie |
AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
CN102309482B (zh) * | 2011-06-20 | 2013-04-10 | 海南良方医药有限公司 | 一种硫酸氢氯吡格雷组合物及其制备方法 |
ES2713566T3 (es) | 2011-07-15 | 2019-05-22 | Boehringer Ingelheim Int | Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
RU2540519C2 (ru) * | 2013-02-05 | 2015-02-10 | Общество с ограниченной ответственностью "Трейдсервис" | Лекарственная форма клопидогрела |
ES2950384T3 (es) | 2014-02-28 | 2023-10-09 | Boehringer Ingelheim Int | Uso médico de un inhibidor de DPP-4 |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
JP2019517542A (ja) | 2016-06-10 | 2019-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | リナグリプチンおよびメトホルミンの組合せ |
CN106176644B (zh) * | 2016-08-18 | 2019-05-14 | 成都新柯力化工科技有限公司 | 一种氯吡格雷硫酸盐固体片剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
CA2019324C (en) * | 1989-07-10 | 1996-08-20 | Robert L. Jerzewski | Fosinopril tablet formulations |
CA2100836C (en) * | 1993-07-19 | 1998-02-03 | Bernard Charles Sherman | PHARMACEUTICAL COMPOSITION |
US5562921A (en) * | 1994-07-15 | 1996-10-08 | Sherman; Bernard C. | Stable solid pharmaceutical compositions containing enalapril maleate |
AU1534699A (en) * | 1997-12-05 | 1999-06-28 | Alza Corporation | Osmotic dosage form comprising first and second coats |
FR2779726B1 (fr) * | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
WO2000001364A1 (en) * | 1998-07-01 | 2000-01-13 | Sun Pharmaceutical Industries Ltd. | Stable pharmaceutical compositions of thieno [3,2-c] pyridine derivatives |
IN191030B (de) * | 2001-01-24 | 2003-09-13 | Cadila Healthcare Ltd | |
CA2343949A1 (en) * | 2001-04-12 | 2002-10-12 | Bernard Charles Sherman | Benazepril hydrochloride tablet formulations |
US6767913B2 (en) * | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
US6800759B2 (en) * | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
IL166593A0 (en) * | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel |
-
2001
- 2001-11-09 CA CA2363053A patent/CA2363053C/en not_active Expired - Fee Related
-
2002
- 2002-11-01 AT AT02257582T patent/ATE279179T1/de not_active IP Right Cessation
- 2002-11-01 EP EP02257582A patent/EP1310245B1/de not_active Revoked
- 2002-11-01 DE DE60201568T patent/DE60201568T2/de not_active Revoked
- 2002-11-04 US US10/286,810 patent/US6914141B2/en not_active Expired - Fee Related
- 2002-11-04 AU AU2002301782A patent/AU2002301782B8/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US20030096837A1 (en) | 2003-05-22 |
US6914141B2 (en) | 2005-07-05 |
AU2002301782B8 (en) | 2006-08-03 |
AU2002301782B2 (en) | 2006-06-01 |
EP1310245A1 (de) | 2003-05-14 |
EP1310245B1 (de) | 2004-10-13 |
DE60201568D1 (de) | 2004-11-18 |
CA2363053C (en) | 2011-01-25 |
DE60201568T2 (de) | 2005-10-20 |
CA2363053A1 (en) | 2003-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE279179T1 (de) | Clopidogrelbisulfathaltige tablettenzubereitung | |
DE60219478D1 (en) | Orale gabe von 6-hydroxy-oxymorphon als analgetikum | |
AU2002301782A1 (en) | Clopidogrel bisulfate tablet formulation | |
ITRM20020240A0 (it) | Dispositivo di sicurezza per un robot da cucina a grande scivolo. | |
AP2005003371A0 (en) | Medication compliance device. | |
IL166079A0 (en) | Sustained-release tablet comprising reboxetine | |
MXPA03006775A (es) | Formulacion farmaceutica. | |
EE200300055A (et) | Hüdrogeeli poolt juhitav ravimi annustamisvorm | |
MXPA03007641A (es) | Formulacion farmaceutica. | |
DE69528838D1 (de) | Verbesserte,ibuprofen und codein enthaltende,pharmazeutische zusammensetzungen | |
NO20041195L (no) | Tablettmater. | |
GB2381180B (en) | Animal access system | |
ATE285753T1 (de) | Lysin enthaltende kautablette | |
HK1062896A1 (en) | Swallow tablet comprising paracetemol | |
ITRM20010369A1 (it) | Tettarella o ciuccio. | |
ZA200403614B (en) | Controlled release tablets of metformin. | |
HUP0303860A3 (en) | A pharmaceutical tablet having a high active ingredient | |
DE60022689D1 (de) | Pharmazeutische desinfektionsmittel, die usninsäure und ein ätherisches öl enthalten | |
GB0118507D0 (en) | Proofers date rape drug detection | |
DE59909714D1 (de) | Calciumhaltige Brausetablette mit einem Antihistaminikum als Wirkstoff | |
NL1023797A1 (nl) | Farmaceutische doseringsvorm die zwangerschapsvriendelijke onderscheidingstekens draagt. | |
GB0112385D0 (en) | Woolford emergency access intruder chain | |
HUP0600158A2 (en) | Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs | |
EP1303309A4 (de) | Schnellzerfallende tablette für tiere | |
TW494753U (en) | Device for shaping Chinese medicine tablets or pellet-shaped food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |